Filing Flows › X4 Pharmaceuticals (XFOR) › Recalls, complaints & regulation
X4 Pharmaceuticals (XFOR): clinical trials
X4 Pharmaceuticals (XFOR) beyond its filings: 2 active clinical trials.
X4 Pharmaceuticals' latest quarter
X4 Pharmaceuticals, Q3 2026: revenue $2.8M (+75% year over year), operating margin -714.0%, net loss $20.2M, operating cash flow −$20.2M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does X4 Pharmaceuticals have?
2 active studies on ClinicalTrials.gov, 1 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.